Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial

PURPOSE: To describe visual outcomes, frequency of treatment and monitoring visits, and anti–vascular endothelial growth factor drugs used in usual care in participants who exited a trial in which treatment for neovascular age-related macular degeneration (nAMD) was initiated with bevacizumab or ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Rebecca N., Reeves, Barnaby C., Phillips, Dawn, Muldrew, Katherine Alyson, Rogers, Chris, Harding, Simon P., Chakravarthy, Usha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471837/
https://www.ncbi.nlm.nih.gov/pubmed/32359843
http://dx.doi.org/10.1016/j.ophtha.2020.03.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471837/
https://www.ncbi.nlm.nih.gov/pubmed/32359843
http://dx.doi.org/10.1016/j.ophtha.2020.03.020

Ejemplares similares